TH vs. MDO, BYD, PLI, ABCN, EMC, FRX, BCT, IPA, MDNA, and ONC
Should you be buying Theratechnologies stock or one of its competitors? The main competitors of Theratechnologies include Manado Gold (MDO), Boyd Group Services (BYD), ProMetic Life Sciences (PLI), VIVO Cannabis (ABCN), Emblem (EMC), Fennec Pharmaceuticals (FRX), BriaCell Therapeutics (BCT), ImmunoPrecise Antibodies (IPA), Medicenna Therapeutics (MDNA), and Oncolytics Biotech (ONC).
Theratechnologies (TSE:TH) and Manado Gold (CVE:MDO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends, community ranking and institutional ownership.
Manado Gold has a net margin of 0.00% compared to Theratechnologies' net margin of -23.04%. Manado Gold's return on equity of 0.00% beat Theratechnologies' return on equity.
Theratechnologies received 252 more outperform votes than Manado Gold when rated by MarketBeat users. However, 70.83% of users gave Manado Gold an outperform vote while only 63.44% of users gave Theratechnologies an outperform vote.
48.9% of Theratechnologies shares are held by institutional investors. 6.3% of Theratechnologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Theratechnologies presently has a consensus price target of C$5.50, indicating a potential upside of 175.00%. Given Theratechnologies' higher probable upside, equities analysts plainly believe Theratechnologies is more favorable than Manado Gold.
Manado Gold has lower revenue, but higher earnings than Theratechnologies. Theratechnologies is trading at a lower price-to-earnings ratio than Manado Gold, indicating that it is currently the more affordable of the two stocks.
In the previous week, Theratechnologies had 1 more articles in the media than Manado Gold. MarketBeat recorded 1 mentions for Theratechnologies and 0 mentions for Manado Gold. Theratechnologies' average media sentiment score of 0.00 equaled Manado Gold'saverage media sentiment score.
Summary
Theratechnologies beats Manado Gold on 7 of the 13 factors compared between the two stocks.
Get Theratechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for TH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Theratechnologies Competitors List
Related Companies and Tools
